Summary

The global post-marketing pharmacovigilance and medical information market size reached USD 6.2 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 13.9 Billion by 2033, exhibiting a growth rate (CAGR) of 9.04% during 2025-2033.

Post-marketing pharmacovigilance and medical information is the practice of monitoring the safety and efficacy of drugs and medical devices after their launch. It includes collection, surveillance, and prevention of adverse effects of new medicines, equipment, and therapies. It helps protect patients from unnecessary harm by clarifying risks concerning benefits and refuting false indications. Besides this, it assists researchers in determining required actions throughout the drug formulation cycle. As a result, post-marketing pharmacovigilance and medical information finds a considerable role in the healthcare industry to assess the accuracy of the delivered information between patients and medical professionals. It is also used in research organizations for regulating drug safety guidelines.

Post-marketing Pharmacovigilance and Medical Information Market Trends:

The growing global geriatric population and the rising occurrence of various chronic medical disorders, such as diabetes, hypertension, dementia, cardiovascular diseases, and osteoporosis, represent one of the key factors increasing the consumption of medicines. In addition, the increasing frequency of lifestyle, respiratory and cardiovascular infections, and neurological and oncological diseases are resulting in the increasing sales of drugs worldwide. This, in turn, is creating a positive market outlook. In line with this, the rising prevalence of Adverse Drug Reactions (ADRs), coupled with the incorporation of advanced ADR reporting tools, is supporting the market growth. Apart from this, the expansion of hospitals, clinics, laboratories, and medical research centers is catalyzing the demand for medications and medical devices across the globe. Moreover, governments of various countries are implementing several initiatives to improve healthcare infrastructure and pharmacovigilance services and maintain medical databases, which is strengthening the market growth. Furthermore, leading market players are focusing on outsourcing pharmacovigilance operations (PVO) and introducing cloud-based medical information systems for optimal accuracy, cost efficiency, risk mitigation, domain, improved timelines, and organizational agility, which is anticipated to drive the market.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global post-marketing pharmacovigilance and medical information market report, along with forecasts at the global, regional and country level from 2025-2033. Our report has categorized the market based on type, product and end user.

Breakup by Type:
? Spontaneous Reporting
? Intensified ADR Reporting
? Targeted Spontaneous Reporting
? Cohort Event Monitoring
? EHR Mining

Breakup by Product:
? Books
? Online Media
? Journals

Breakup by End User:
? Hospitals
? Research Organization

Breakup by Region:
? North America
o United States
o Canada
? Asia-Pacific
o China
o Japan
o India
o South Korea
o Australia
o Indonesia
o Others
? Europe
o Germany
o France
o United Kingdom
o Italy
o Spain
o Russia
o Others
? Latin America
o Brazil
o Mexico
o Others
? Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Accenture Plc., ArisGlobal, Cognizant Technology Solutions Corporation, Ergomed Plc, F. Hoffmann-La Roche Ltd., Icon Plc, Parexel International Corporation, Pharmaceutical Product Development, Inc. and Wipro Ltd.

Key Questions Answered in This Report

1.How big is the global post-marketing pharmacovigilance and medical information market?
2.What is the expected growth rate of the global post-marketing pharmacovigilance and medical information market during 2025-2033?
3.What are the key factors driving the global post-marketing pharmacovigilance and medical information market?
4.What has been the impact of COVID-19 on the global post-marketing pharmacovigilance and medical information market?
5.What is the breakup of the global post-marketing pharmacovigilance and medical information market based on the type?
6.What is the breakup of the global post-marketing pharmacovigilance and medical information market based on the end user?
7.What are the key regions in the global post-marketing pharmacovigilance and medical information market?
8.Who are the key players/companies in the global post-marketing pharmacovigilance and medical information market?

ページTOPに戻る

Table of Contents

?1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Post-marketing Pharmacovigilance and Medical Information Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Type
6.1 Spontaneous Reporting
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Intensified ADR Reporting
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Targeted Spontaneous Reporting
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Cohort Event Monitoring
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 EHR Mining
6.5.1 Market Trends
6.5.2 Market Forecast
7 Market Breakup by Product
7.1 Books
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Online Media
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Journals
7.3.1 Market Trends
7.3.2 Market Forecast
8 Market Breakup by End User
8.1 Hospitals
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Research Organization
8.2.1 Market Trends
8.2.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Accenture Plc.
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 ArisGlobal
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 Cognizant Technology Solutions Corporation
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Ergomed Plc
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.5 F. Hoffmann-La Roche Ltd.
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 SWOT Analysis
14.3.6 Icon Plc
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 Parexel International Corporation
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 SWOT Analysis
14.3.8 Pharmaceutical Product Development, Inc.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 SWOT Analysis
14.3.9 Wipro Ltd.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials

ページTOPに戻る

List of Tables/Graphs

List of Figures

Figure 1: Global: Post-marketing Pharmacovigilance and Medical Information Market: Major Drivers and Challenges
Figure 2: Global: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 4: Global: Post-marketing Pharmacovigilance and Medical Information Market: Breakup by Type (in %), 2024
Figure 5: Global: Post-marketing Pharmacovigilance and Medical Information Market: Breakup by Product (in %), 2024
Figure 6: Global: Post-marketing Pharmacovigilance and Medical Information Market: Breakup by End User (in %), 2024
Figure 7: Global: Post-marketing Pharmacovigilance and Medical Information Market: Breakup by Region (in %), 2024
Figure 8: Global: Post-marketing Pharmacovigilance and Medical Information (Spontaneous Reporting) Market: Sales Value (in Million USD), 2019 & 2024
Figure 9: Global: Post-marketing Pharmacovigilance and Medical Information (Spontaneous Reporting) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 10: Global: Post-marketing Pharmacovigilance and Medical Information (Intensified ADR Reporting) Market: Sales Value (in Million USD), 2019 & 2024
Figure 11: Global: Post-marketing Pharmacovigilance and Medical Information (Intensified ADR Reporting) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 12: Global: Post-marketing Pharmacovigilance and Medical Information (Targeted Spontaneous Reporting) Market: Sales Value (in Million USD), 2019 & 2024
Figure 13: Global: Post-marketing Pharmacovigilance and Medical Information (Targeted Spontaneous Reporting) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 14: Global: Post-marketing Pharmacovigilance and Medical Information (Cohort Event Monitoring) Market: Sales Value (in Million USD), 2019 & 2024
Figure 15: Global: Post-marketing Pharmacovigilance and Medical Information (Cohort Event Monitoring) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 16: Global: Post-marketing Pharmacovigilance and Medical Information (EHR Mining) Market: Sales Value (in Million USD), 2019 & 2024
Figure 17: Global: Post-marketing Pharmacovigilance and Medical Information (EHR Mining) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 18: Global: Post-marketing Pharmacovigilance and Medical Information (Books) Market: Sales Value (in Million USD), 2019 & 2024
Figure 19: Global: Post-marketing Pharmacovigilance and Medical Information (Books) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 20: Global: Post-marketing Pharmacovigilance and Medical Information (Online Media) Market: Sales Value (in Million USD), 2019 & 2024
Figure 21: Global: Post-marketing Pharmacovigilance and Medical Information (Online Media) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 22: Global: Post-marketing Pharmacovigilance and Medical Information (Journals) Market: Sales Value (in Million USD), 2019 & 2024
Figure 23: Global: Post-marketing Pharmacovigilance and Medical Information (Journals) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 24: Global: Post-marketing Pharmacovigilance and Medical Information (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
Figure 25: Global: Post-marketing Pharmacovigilance and Medical Information (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 26: Global: Post-marketing Pharmacovigilance and Medical Information (Research Organization) Market: Sales Value (in Million USD), 2019 & 2024
Figure 27: Global: Post-marketing Pharmacovigilance and Medical Information (Research Organization) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 28: North America: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2019 & 2024
Figure 29: North America: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 30: United States: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2019 & 2024
Figure 31: United States: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 32: Canada: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2019 & 2024
Figure 33: Canada: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 34: Asia-Pacific: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2019 & 2024
Figure 35: Asia-Pacific: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 36: China: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2019 & 2024
Figure 37: China: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 38: Japan: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2019 & 2024
Figure 39: Japan: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 40: India: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2019 & 2024
Figure 41: India: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 42: South Korea: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2019 & 2024
Figure 43: South Korea: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 44: Australia: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2019 & 2024
Figure 45: Australia: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 46: Indonesia: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2019 & 2024
Figure 47: Indonesia: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 48: Others: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2019 & 2024
Figure 49: Others: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 50: Europe: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2019 & 2024
Figure 51: Europe: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 52: Germany: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2019 & 2024
Figure 53: Germany: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 54: France: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2019 & 2024
Figure 55: France: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 56: United Kingdom: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2019 & 2024
Figure 57: United Kingdom: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 58: Italy: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2019 & 2024
Figure 59: Italy: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 60: Spain: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2019 & 2024
Figure 61: Spain: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 62: Russia: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2019 & 2024
Figure 63: Russia: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 64: Others: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2019 & 2024
Figure 65: Others: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 66: Latin America: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2019 & 2024
Figure 67: Latin America: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 68: Brazil: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2019 & 2024
Figure 69: Brazil: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 70: Mexico: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2019 & 2024
Figure 71: Mexico: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 72: Others: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2019 & 2024
Figure 73: Others: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 74: Middle East and Africa: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2019 & 2024
Figure 75: Middle East and Africa: Post-marketing Pharmacovigilance and Medical Information Market: Breakup by Country (in %), 2024
Figure 76: Middle East and Africa: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 77: Global: Post-marketing Pharmacovigilance and Medical Information Industry: SWOT Analysis
Figure 78: Global: Post-marketing Pharmacovigilance and Medical Information Industry: Value Chain Analysis
Figure 79: Global: Post-marketing Pharmacovigilance and Medical Information Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Post-marketing Pharmacovigilance and Medical Information Market: Key Industry Highlights, 2024 and 2033
Table 2: Global: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Breakup by Type (in Million USD), 2025-2033
Table 3: Global: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Breakup by Product (in Million USD), 2025-2033
Table 4: Global: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Breakup by End User (in Million USD), 2025-2033
Table 5: Global: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 6: Global: Post-marketing Pharmacovigilance and Medical Information Market: Competitive Structure
Table 7: Global: Post-marketing Pharmacovigilance and Medical Information Market: Key Players